C-CDA R2.1 Comment Submission
SDWG completed an update to Consolidated CDA R2.0 to enable a C-CDA 2.1 instance to be created that can be used without requiring change to the product supporting C-CDA 1.1. A full description of the project is available on Project Insight Consolidated CDA DSTU 2013 Update (1014). This update is available to HL7 members INSERT_LINK_C-CDAR2.1 for review prior to reconciliation and publication. As a minor DSTU update, this new version will not go through the usual HL7 balloting process but will use the DSTU Update process with industry review on the HL7 wiki.
Before submitting comments, please review the C-CDA R2.1 Approved Compatibility Principles
Changes open for comment:
- Volume 1 edits
- Volume 2 edits to prose, figures, and specific conformance statements
Edits available for comment are identified by....
During the comment period 7/1/2015 - 7/13/2015, please submit your comments on this wiki page including at least your name, item, existing wording, proposed wording, and comment. Thank you.
Comments
Enter your comments below this line.
| Item | Summary | DSTU Comment # | Link to full DSTU Comment |
|---|---|---|---|
| 1 | Incorporation of new code for use in the Colon TNM Category 2.16.840.1.113883.10.20.30.3.54 template. And, refine the National Cancer Institute (NCI) Common Toxicity Criteria Adverse Event (CTCAE) value set (2.16.840.1.113883.11.20.11.35) to include new codes and clarify the set of concepts to be included. Change the name of the value set to align with the refined purpose. New value set name is "Neuropathy at end of treament grade" to align with the Colon Cancer Adjuvant Treatment Plan and Summary form. | 600 | comment link |
